Using a qRT-PCR approach we demonstrated that RET gene expression levels are higher in MTC cases harboring a RET somatic mutation than in cases with a RAS somatic mutation or MTC cases without any of these mutations. This evidence concerns the gene RET and medullary thyroid gland carcinoma.